BioAtla(BCAB)
$1.83-0.26 (-8.50%)
BCAB
BioAtla financials statements
$1.83
At close:-0.26 (-8.50%)
Want to see BCAB full AI Analyst Report?
BioAtla (BCAB) Ratios
785 Followers
BioAtla Ratios
BCAB's free cash flow for Q2 2026 was $-419.00K. For the 2026 fiscal year, BCAB's free cash flow was increased by $0.00 and operating cash flow was $-419.00K. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.37 | 3.52 | 4.11 | 9.53 | 12.48 |
| Quick Ratio | 0.37 | 3.52 | 4.11 | 9.53 | 12.48 |
| Cash Ratio | 0.32 | 3.37 | 3.93 | 9.32 | 12.36 |
| Solvency Ratio | -1.18 | -1.80 | -2.50 | -2.29 | -2.16 |
| Operating Cash Flow Ratio | -2.20 | -4.95 | -3.67 | -3.91 | -3.14 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ -42.00M | $ 13.07M | $ 67.42M | $ 175.03M | $ 203.69M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.45 | 0.02 | 0.02 | 0.02 | 0.02 |
| Debt-to-Equity Ratio | -0.17 | 0.06 | 0.03 | 0.02 | 0.03 |
| Debt-to-Capital Ratio | -0.21 | 0.06 | 0.03 | 0.02 | 0.02 |
| Long-Term Debt-to-Capital Ratio | -0.15 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | -0.38 | 3.67 | 1.69 | 1.25 | 1.21 |
| Debt Service Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | -31356.33 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | -32146.67 |
| Debt to Market Cap | 0.14 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 5.27 | 0.86 | 0.05 | 0.10 | 0.16 |
| Net Debt to EBITDA | 0.02 | 0.70 | 0.89 | 2.01 | 2.55 |
| Profitability Margins | |||||
| Gross Profit Margin | -2053.65% | 91.59% | 0.00% | 0.00% | 100.00% |
| EBIT Margin | -2980.35% | -634.33% | 0.00% | 0.00% | -38159.60% |
| EBITDA Margin | -2961.70% | -625.92% | 0.00% | 0.00% | -37627.60% |
| Operating Profit Margin | -2965.25% | -672.21% | 0.00% | 0.00% | -38576.00% |
| Pretax Profit Margin | -2980.35% | -634.33% | 0.00% | 0.00% | -38160.80% |
| Net Profit Margin | -2980.35% | -634.33% | 0.00% | 0.00% | -38160.80% |
| Continuous Operations Profit Margin | -2980.35% | -634.33% | 0.00% | 0.00% | -38160.80% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 98.87% | 100.00% |
| EBT Per EBIT | 100.51% | 94.36% | 95.20% | 98.47% | 98.92% |
| Return on Assets (ROA) | -431.06% | -133.10% | -103.18% | -46.64% | -37.50% |
| Return on Equity (ROE) | 164.71% | -489.14% | -174.70% | -58.38% | -45.25% |
| Return on Capital Employed (ROCE) | 732.70% | -195.19% | -142.02% | -53.37% | -41.11% |
| Return on Invested Capital (ROIC) | 889.53% | -190.98% | -139.54% | -52.98% | -40.86% |
| Return on Tangible Assets | -431.06% | -133.10% | -103.18% | -46.64% | -37.50% |
| Earnings Yield | -178.45% | -242.98% | -105.04% | -32.78% | -14.06% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 5.26 | 0.49 | 0.32 | 0.28 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.35 | 9.24 | 0.00 | 0.00 | 0.04 |
| Asset Turnover | 0.14 | 0.21 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.18 | 0.18 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -69.44 | -750.52 | -1141.63 | -1288.00 | 0.00 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 69.44 | 750.52 | 1141.63 | 1288.00 | 0.00 |
| Operating Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -40.97 | -74.05 | -2.18 | -2.32 | -1.80 |
| Free Cash Flow Per Share | -40.97 | -74.05 | -2.18 | -2.33 | -1.83 |
| Dividend Paid and CapEx Coverage Ratio | 0.00 | 0.00 | -1061.38 | -337.39 | -67.33 |
| Capital Expenditure Coverage Ratio | 0.00 | 0.00 | -1061.38 | -337.39 | -67.33 |
| Operating Cash Flow Coverage Ratio | -7.77 | -86.05 | -42.28 | -22.71 | -11.58 |
| Operating Cash Flow to Sales Ratio | -24.10 | -6.54 | 0.00 | 0.00 | -248.86 |
| Free Cash Flow Yield | -144.31% | -250.50% | -88.58% | -28.24% | -9.31% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.56 | -0.41 | -0.95 | -3.05 | -7.11 |
| Price-to-Sales (P/S) Ratio | 16.70 | 2.61 | 0.00 | 0.00 | 2713.75 |
| Price-to-Book (P/B) Ratio | -0.92 | 2.01 | 1.66 | 1.78 | 3.22 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -0.69 | -0.40 | -1.13 | -3.54 | -10.75 |
| Price-to-Operating Cash Flow Ratio | -0.69 | -0.40 | -1.13 | -3.55 | -10.90 |
| Price-to-Earnings Growth (PEG) Ratio | 0.02 | 0.01 | 0.16 | 4.21 | -0.04 |
| Enterprise Value Multiple | -0.55 | 0.28 | -0.07 | -1.04 | -4.66 |
| Enterprise Value | 32.48M | -19.49M | 8.52M | 109.62M | 438.83M |
| EV to EBITDA | -0.55 | 0.28 | -0.07 | -1.04 | -4.66 |
| EV to Sales | 16.24 | -1.77 | 0.00 | 0.00 | 1755.32 |
| EV to Free Cash Flow | -0.67 | 0.27 | -0.08 | -1.21 | -6.95 |
| EV to Operating Cash Flow | -0.67 | 0.27 | -0.08 | -1.21 | -7.05 |
| Tangible Book Value Per Share | -30.76 | 14.68 | 1.48 | 4.63 | 6.10 |
| Shareholders’ Equity Per Share | -30.76 | 14.68 | 1.48 | 4.63 | 6.10 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 1.70 | 11.32 | 0.00 | 0.00 | 0.01 |
| Net Income Per Share | -50.66 | -71.83 | -2.58 | -2.70 | -2.76 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 0.99 | 1.00 |
| Interest Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Research & Development to Revenue | 21.79 | 5.74 | 0.00 | 0.00 | 233.10 |
| SG&A to Revenue | 8.82 | 1.99 | 0.00 | 0.00 | 153.66 |
| Stock-Based Compensation to Revenue | 2.72 | 0.81 | 0.00 | 0.00 | 100.47 |
| Income Quality | 0.81 | 1.03 | 0.84 | 0.85 | 0.65 |
Currency in USD
